The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against

Jana Seele1, Lena-Maria Hillermann1, Andreas Beineke2

  • 1Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Hannover, Germany.

Vaccine
|April 1, 2015
PubMed

Insights

A novel recombinant vaccine using Streptococcus suis's IgM degrading enzyme (IdeSsuis) protected piglets from disease. This IdeSsuis vaccine shows high efficacy against S. suis infections in pigs.

Area of Science:

  • Veterinary Microbiology
  • Immunology
  • Vaccine Development

Background:

  • Streptococcus suis is a significant swine pathogen causing severe diseases like meningitis and arthritis.
  • A specific immunoglobulin M (IgM) degrading enzyme, IdeSsuis, has been identified in S. suis strains.
  • The potential of IdeSsuis as a vaccine candidate against S. suis infections requires investigation.

Purpose of the Study:

  • To evaluate the immunogenicity and protective efficacy of a recombinant IdeSsuis (rIdeSsuis) vaccine in pigs.
  • To assess the impact of rIdeSsuis vaccination on S. suis survival in porcine blood.

Main Methods:

  • Production and administration of recombinant IdeSsuis (rIdeSsuis) vaccine to piglets.
  • Challenge with virulent S. suis serotype 2 and monitoring of clinical outcomes (mortality, morbidity).
  • Measurement of anti-IdeSsuis antibodies and assessment of S. suis killing in porcine blood ex vivo.

Main Results:

  • Vaccination with rIdeSsuis successfully elicited neutralizing antibodies against IdeSsuis.
  • Piglets vaccinated with rIdeSsuis demonstrated complete protection against mortality and severe morbidity following S. suis challenge.
  • rIdeSsuis vaccination significantly enhanced the killing of S. suis in porcine blood, reducing bacterial survival.

Conclusions:

  • Recombinant IdeSsuis (rIdeSsuis) is a highly immunogenic and protective antigen in pigs.
  • The rIdeSsuis vaccine offers a promising strategy for controlling Streptococcus suis infections in swine populations.

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
69.0K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.9K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
4.1K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
87.9K
Antibody Structure and Classes01:25

Antibody Structure and Classes

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
10.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
88.0K